Arrowstreet Capital
DERM icon

Arrowstreet Capital’s Journey Medical DERM Stock Holding History

Arrowstreet Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80K Buy
+11,305
New +$64.6K ﹤0.01% 1878

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Arrowstreet Capital's DERM Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Journey Medical (DERM) in Q2 2026: 11,305 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #1878 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Arrowstreet Capital held 11,305 shares of Journey Medical worth $80K as of Q2 2026.
  • Journey Medical was a new Arrowstreet Capital position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1878 holding.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.